{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:07:30Z","timestamp":1787591250036,"version":"build-2736575974"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:p>The definition of sepsis has evolved significantly over the past three decades. Today, sepsis is defined as a dysregulated host immune response to microbial invasion leading to end organ dysfunction. Septic shock is characterized by hypotension requiring vasopressors after adequate fluid resuscitation with elevated lactate. Early recognition and intervention remain hallmarks for sepsis management. We addressed the current literature and assimilated thought regarding optimum initial resuscitation of the patient with sepsis. A nuanced understanding of the physiology of lactate is provided in our review. Physiologic and practical knowledge of steroid and vasopressor therapy for sepsis is crucial and addressed. As blood purification may interest the nephrologist treating sepsis, we have also added a brief discussion of its status.<\/jats:p>","DOI":"10.2215\/cjn.14381121","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T11:54:17Z","timestamp":1653306857000},"page":"880-889","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["Sepsis Management for the Nephrologist"],"prefix":"10.2215","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7511-2574","authenticated-orcid":false,"given":"Sharad","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Critical Care, Rowan University Cooper Medical School, Camden, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Puri","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Cooper Hospital University Medical Center, Camden, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Phillip","family":"Dellinger","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Cooper Hospital University Medical Center, Camden, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,6]]},"reference":[{"key":"B1-20241015","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.2014.2637","article-title":"Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012","volume":"311","author":"Kaukonen","year":"2014","journal-title":"JAMA"},{"key":"B2-20241015","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"key":"B3-20241015","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00134-008-1367-2","article-title":"Acute kidney injury in septic shock: Clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy","volume":"35","author":"Bagshaw","year":"2009","journal-title":"Intensive Care Med"},{"key":"B4-20241015","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1097\/CCM.0000000000005357","article-title":"Executive summary: Surviving Sepsis Campaign: International guidelines for the management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"B5-20241015","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"B6-20241015","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"B7-20241015","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","article-title":"Acute kidney injury from sepsis: Current concepts, epidemiology, pathophysiology, prevention and treatment","volume":"96","author":"Peerapornratana","year":"2019","journal-title":"Kidney Int"},{"key":"B8-20241015","article-title":"KDIGO Clinical Practice Guidelines for Acute Kidney Injury"},{"key":"B9-20241015","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"B10-20241015","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1097\/CCM.0000000000005151","article-title":"Antibiotic administration and timing: Risks, delay, zombies","volume":"49","author":"Townsend","year":"2021","journal-title":"Crit Care Med"},{"key":"B11-20241015","first-page":"2050312119835043","article-title":"Sepsis: The evolution in definition, pathophysiology, and management","volume":"7","author":"Gyawali","year":"2019","journal-title":"AGE Open Med"},{"key":"B12-20241015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jcrc.2018.11.009","article-title":"Epidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systems","volume":"50","author":"Saito","year":"2019","journal-title":"J Crit Care"},{"key":"B13-20241015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJMra032401","article-title":"Acute renal failure and sepsis","volume":"351","author":"Schrier","year":"2004","journal-title":"N Engl J Med"},{"key":"B14-20241015","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1097\/CCM.0b013e3182a639da","article-title":"Renal histopathology during experimental septic acute kidney injury and recovery","volume":"42","author":"Langenberg","year":"2014","journal-title":"Crit Care Med"},{"key":"B15-20241015","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/00003246-199907000-00002","article-title":"Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction","volume":"27","author":"Hotchkiss","year":"1999","journal-title":"Crit Care Med"},{"key":"B16-20241015","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/MCC.0000000000000356","article-title":"Sepsis-induced acute kidney injury","volume":"22","author":"G\u00f3mez","year":"2016","journal-title":"Curr Opin Crit Care"},{"key":"B17-20241015","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/ndt\/gfu052","article-title":"Glomerular haemodynamics, the renal sympathetic nervous system and sepsis-induced acute kidney injury","volume":"29","author":"Calzavacca","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"B18-20241015","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00134-017-4817-x","article-title":"Fluid management in acute kidney injury","volume":"43","author":"Perner","year":"2017","journal-title":"Intensive Care Med"},{"key":"B19-20241015","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jama.2017.0131","article-title":"Management of sepsis and septic shock","volume":"317","author":"Howell","year":"2017","journal-title":"JAMA"},{"key":"B20-20241015","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1097\/CCM.0000000000003261","article-title":"Compliance with the national SEP-1 quality measure and association with sepsis outcomes: A multicenter retrospective cohort study","volume":"46","author":"Rhee","year":"2018","journal-title":"Crit Care Med"},{"key":"B21-20241015","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/ki.2009.159","article-title":"Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury","volume":"76","author":"Bouchard","year":"2009","journal-title":"Kidney Int"},{"key":"B22-20241015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.5603\/AIT.2014.0060","article-title":"Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: A systematic review with suggestions for clinical practice","volume":"46","author":"Malbrain","year":"2014","journal-title":"Anaesthesiol Intensive Ther"},{"key":"B23-20241015","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/CCM.0000000000003892","article-title":"Antibiotic- and fluid-focused bundles potentially improve sepsis management, but high-quality evidence is lacking for the specificity required in the Centers for Medicare and Medicaid Service\u2019s Sepsis Bundle (SEP-1)","volume":"47","author":"Pepper","year":"2019","journal-title":"Crit Care Med"},{"key":"B24-20241015","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1056\/NEJMoa1401602","article-title":"A randomized trial of protocol-based care for early septic shock","volume":"370","author":"Yealy","year":"2014","journal-title":"N Engl J Med"},{"key":"B25-20241015","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJMoa1404380","article-title":"Goal-directed resuscitation for patients with early septic shock","volume":"371","author":"Peake","year":"2014","journal-title":"N Engl J Med"},{"key":"B26-20241015","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa1500896","article-title":"Trial of early, goal-directed resuscitation for septic shock","volume":"372","author":"Mouncey","year":"2015","journal-title":"N Engl J Med"},{"key":"B27-20241015","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1056\/NEJMoa1701380","article-title":"Early, Goal-directed therapy for septic shock\u2014A patient-level meta-analysis","volume":"376","author":"Rowan","year":"2017","journal-title":"N Engl J Med"},{"key":"B28-20241015","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/aas.13434","article-title":"Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial: Protocol and statistical analysis plan","volume":"63","author":"Meyhoff","year":"2019","journal-title":"Acta Anaesthesiol Scand"},{"key":"B29-20241015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.annemergmed.2018.03.039","article-title":"Liberal versus restrictive intravenous fluid therapy for early septic shock: Rationale for a randomized trial","volume":"72","author":"Self","year":"2018","journal-title":"Ann Emerg Med"},{"key":"B30-20241015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13613-021-00817-5","article-title":"Predictors of fluid responsiveness in critically ill patients mechanically ventilated at low tidal volumes: Systematic review and meta-analysis","volume":"11","author":"Alvarado S\u00e1nchez","year":"2021","journal-title":"Ann Intensive Care"},{"key":"B31-20241015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13613-021-00925-2","article-title":"High mean arterial pressure target to improve sepsis-associated acute kidney injury in patients with prior hypertension: A feasibility study","volume":"11","author":"Dewitte","year":"2021","journal-title":"Ann Intensive Care"},{"key":"B32-20241015","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus low blood-pressure target in patients with septic shock","volume":"370","author":"Asfar","year":"2014","journal-title":"N Engl J Med"},{"key":"B33-20241015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13054-020-2770-5","article-title":"Elevated central venous pressure is associated with increased mortality and acute kidney injury in critically ill patients: A meta-analysis","volume":"24","author":"Chen","year":"2020","journal-title":"Crit Care"},{"key":"B34-20241015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jcrc.2018.03.016","article-title":"Value of the combination of renal resistance index and central venous pressure in the early prediction of sepsis-induced acute kidney injury","volume":"45","author":"Song","year":"2018","journal-title":"J Crit Care"},{"key":"B35-20241015","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1711584","article-title":"Balanced crystalloids versus saline in critically ill adults","volume":"378","author":"Semler","year":"2018","journal-title":"N Engl J Med"},{"key":"B36-20241015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1711586","article-title":"Balanced crystalloids versus saline in noncritically ill adults","volume":"378","author":"Self","year":"2018","journal-title":"N Engl J Med"},{"key":"B37-20241015","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.2015.12334","article-title":"Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: The SPLIT randomized clinical trial","volume":"314","author":"Young","year":"2015","journal-title":"JAMA"},{"key":"B38-20241015","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1001\/jama.2021.11684","article-title":"Effect of intravenous fluid treatment with a balanced solution vs 0.9% saline solution on mortality in critically ill patients: The BaSICS randomized clinical trial","volume":"326","author":"Zampieri","year":"2021","journal-title":"JAMA"},{"key":"B39-20241015","first-page":"239","article-title":"The Plasma-Lyte 148 v Saline (PLUS) study protocol: A multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality","volume":"19","author":"Hammond","year":"2017","journal-title":"Crit Care Resusc"},{"key":"B40-20241015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1060028019866420","article-title":"Balanced crystalloids versus saline in critically ill adults\u2014A systematic review with meta-analysis","volume":"54","author":"Hammond","year":"2020","journal-title":"Ann Pharmacother"},{"key":"B41-20241015","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jama.2013.430","article-title":"Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: A systematic review and meta-analysis","volume":"309","author":"Zarychanski","year":"2013","journal-title":"JAMA"},{"key":"B42-20241015","doi-asserted-by":"crossref","first-page":"g4561","DOI":"10.1136\/bmj.g4561","article-title":"Randomised trials of human albumin for adults with sepsis: Systematic review and meta-analysis with trial sequential analysis of all-cause mortality","volume":"349","author":"Patel","year":"2014","journal-title":"BMJ"},{"key":"B43-20241015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13613-020-00697-1","article-title":"Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: A review","volume":"10","author":"Aldecoa","year":"2020","journal-title":"Ann Intensive Care"},{"key":"B44-20241015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mito.2014.05.007","article-title":"Comprehensive review on lactate metabolism in human health","volume":"17","author":"Adeva-Andany","year":"2014","journal-title":"Mitochondrion"},{"key":"B45-20241015","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/cc1518","article-title":"Bench-to-bedside review: Lactate and the kidney","volume":"6","author":"Bellomo","year":"2002","journal-title":"Crit Care"},{"issue":"Suppl 17","key":"B46-20241015","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1681\/ASN.V12suppl_1s15","article-title":"Lactic acidosis update for critical care clinicians","volume":"12","author":"Luft","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"B47-20241015","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jama.2010.158","article-title":"Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: A randomized clinical trial","volume":"303","author":"Jones","year":"2010","journal-title":"JAMA"},{"key":"B48-20241015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5492\/wjccm.v5.i1.47","article-title":"Use of venous-to-arterial carbon dioxide tension difference to guide resuscitation therapy in septic shock","volume":"5","author":"Mallat","year":"2016","journal-title":"World J Crit Care Med"},{"key":"B49-20241015","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1097\/CCM.0b013e318275cece","article-title":"Lactate and venoarterial carbon dioxide difference\/arterial-venous oxygen difference ratio, but not central venous oxygen saturation, predict increase in oxygen consumption in fluid responders","volume":"41","author":"Monnet","year":"2013","journal-title":"Crit Care Med"},{"key":"B50-20241015","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/jama.2019.0071","article-title":"Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: The ANDROMEDA-SHOCK randomized clinical trial","volume":"321","author":"Hern\u00e1ndez","year":"2019","journal-title":"JAMA"},{"issue":"Suppl 1","key":"B51-20241015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1179\/acb.2007.62.s1.005","article-title":"Continuous intra-abdominal pressure monitoring","volume":"62","author":"Balogh","year":"2007","journal-title":"Acta Clin Belg"},{"key":"B52-20241015","doi-asserted-by":"crossref","first-page":"R98","DOI":"10.1186\/cc4962","article-title":"Effect of bladder volume on measured intravesical pressure: A prospective cohort study","volume":"10","author":"Malbrain","year":"2006","journal-title":"Crit Care"},{"key":"B53-20241015","first-page":"45","article-title":"Fluid therapy and perfusional considerations during resuscitation in critically ill patients with intra-abdominal hypertension","volume":"47","author":"Regli","year":"2015","journal-title":"Anaesthesiol Intensive Ther"},{"key":"B54-20241015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13089-021-00232-8","article-title":"Clinical applications of the venous excess ultrasound (VExUS) score: Conceptual review and case series","volume":"13","author":"Rola","year":"2021","journal-title":"Ultrasound J"},{"issue":"Suppl 3","key":"B55-20241015","first-page":"S94","article-title":"Fluid overload and acute kidney injury","volume":"24","author":"Patil","year":"2020","journal-title":"Indian J Crit Care Med"},{"key":"B56-20241015","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(88)91851-X","article-title":"Raised venous pressure: A direct cause of renal sodium retention in oedema?","volume":"1","author":"Firth","year":"1988","journal-title":"Lancet"},{"key":"B57-20241015","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJMoa2000741","article-title":"Timing of initiation of renal-replacement therapy in acute kidney injury","volume":"383","author":"Bagshaw","year":"2020","journal-title":"N Engl J Med"},{"key":"B58-20241015","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1001\/jama.2016.5828","article-title":"Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: The ELAIN randomized clinical trial","volume":"315","author":"Zarbock","year":"2016","journal-title":"JAMA"},{"key":"B59-20241015","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa1803213","article-title":"Timing of renal-replacement therapy in patients with acute kidney injury and sepsis","volume":"379","author":"Barbar","year":"2018","journal-title":"N Engl J Med"},{"key":"B60-20241015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13054-018-2021-1","article-title":"Early versus standard initiation of renal replacement therapy in furosemide stress test non-responsive acute kidney injury patients (the FST trial)","volume":"22","author":"Lumlertgul","year":"2018","journal-title":"Crit Care"},{"key":"B61-20241015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13613-016-0149-1","article-title":"The passive leg raising test to guide fluid removal in critically ill patients","volume":"6","author":"Monnet","year":"2016","journal-title":"Ann Intensive Care"},{"key":"B62-20241015","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/1742-6723.13406","article-title":"Safety of peripheral administration of vasopressor medications: A systematic review","volume":"32","author":"Tian","year":"2020","journal-title":"Emerg Med Australas"},{"key":"B63-20241015","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1164\/rccm.201806-1034OC","article-title":"Early use of norepinephrine in septic shock resuscitation (CENSER). A randomized trial","volume":"199","author":"Permpikul","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B64-20241015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00134-009-1687-x","article-title":"The effects of vasopressin on acute kidney injury in septic shock","volume":"36","author":"Gordon","year":"2010","journal-title":"Intensive Care Med"},{"key":"B65-20241015","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"B66-20241015","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0140-6736(07)61344-0","article-title":"Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: A randomised trial","volume":"370","author":"Annane","year":"2007","journal-title":"Lancet"},{"key":"B67-20241015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"B68-20241015","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ajem.2019.03.026","article-title":"Angiotensin II in septic shock","volume":"37","author":"Jadhav","year":"2019","journal-title":"Am J Emerg Med"},{"key":"B69-20241015","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"key":"B70-20241015","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"key":"B71-20241015","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2018.14618","article-title":"Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: The EUPHRATES randomized clinical trial","volume":"320","author":"Dellinger","year":"2018","journal-title":"JAMA"},{"key":"B72-20241015","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.2009.856","article-title":"Early use of polymyxin B hemoperfusion in abdominal septic shock: The EUPHAS randomized controlled trial","volume":"301","author":"Cruz","year":"2009","journal-title":"JAMA"},{"key":"B73-20241015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13054-019-2399-4","article-title":"Cytokine clearance with CytoSorb\u00ae during cardiac surgery: A pilot randomized controlled trial","volume":"23","author":"Poli","year":"2019","journal-title":"Crit Care"},{"key":"B74-20241015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/cc14210","article-title":"Clinical experience of using a novel extracorporeal cytokine adsorption column for treatment of septic shock with multiorgan failure","volume":"19","author":"Sathe","year":"2015","journal-title":"Crit Care"},{"key":"B75-20241015","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13054-018-2181-z","article-title":"Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: The promises and the pitfalls","volume":"22","author":"Ankawi","year":"2018","journal-title":"Crit Care"},{"key":"B76-20241015","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00134-006-0118-5","article-title":"High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock","volume":"32","author":"Cornejo","year":"2006","journal-title":"Intensive Care Med"},{"key":"B77-20241015","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1007\/s00134-008-1127-3","article-title":"A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock","volume":"34","author":"Boussekey","year":"2008","journal-title":"Intensive Care Med"},{"key":"B78-20241015","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00134-013-2967-z","article-title":"High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): A multicentre randomized controlled trial","volume":"39","author":"Joannes-Boyau","year":"2013","journal-title":"Intensive Care Med"},{"key":"B79-20241015","first-page":"CD008075","article-title":"High-volume haemofiltration for sepsis","volume":"1","author":"Borthwick","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B80-20241015","doi-asserted-by":"crossref","first-page":"e0220444","DOI":"10.1371\/journal.pone.0220444","article-title":"Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: A randomized crossover double-blind study","volume":"14","author":"Broman","year":"2019","journal-title":"PLoS One"},{"key":"B81-20241015","doi-asserted-by":"crossref","first-page":"817793","DOI":"10.3389\/fphar.2022.817793","article-title":"Continuous renal replacement therapy with oXiris filter may not be an effective resolution to alleviate cytokine release syndrome in non-AKI patients with severe and critical COVID-19","volume":"13","author":"Kang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B82-20241015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/0391398820917150","article-title":"The haemodynamic effects of oXiris haemofilter in septic shock patients requiring renal support: A single-centre experience","volume":"44","author":"Lumlertgul","year":"2021","journal-title":"Int J Artif Organs"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.14381121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:44:14Z","timestamp":1786369454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.14381121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.14381121","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}